Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Net income as a percentage of revenue
5Y CAGR
-12.2%/yr
Long-term compound
Percentile
P55
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.39% | +157.1% |
| 2024 | -4.18% | -19.2% |
| 2023 | -3.51% | +40.3% |
| 2022 | -5.88% | -1257.9% |
| 2021 | 0.51% | -88.9% |
| 2020 | 4.57% | +120.5% |
| 2019 | -22.25% | -118.0% |
| 2018 | -10.21% | -162.9% |
| 2017 | 16.22% | -20.4% |
| 2016 | 20.37% | - |